Brown Advisory’s Ventyx Biosciences VTYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-37,160
Closed -$336K 1467
2025
Q4
$336K Hold
37,160
﹤0.01% 1184
2025
Q3
$116K Hold
37,160
﹤0.01% 1352
2025
Q2
$79.5K Hold
37,160
﹤0.01% 1334
2025
Q1
$42.7K Hold
37,160
﹤0.01% 1311
2024
Q4
$81.4K Hold
37,160
﹤0.01% 1319
2024
Q3
$81K Hold
37,160
﹤0.01% 1241
2024
Q2
$85.8K Hold
37,160
﹤0.01% 1199
2024
Q1
$204K Sell
37,160
-4,600
-11% -$21K ﹤0.01% 1184
2023
Q4
$103K Sell
41,760
-721
-2% -$6.85K ﹤0.01% 1185
2023
Q3
$1.48M Buy
42,481
+11,075
+35% +$383K ﹤0.01% 666
2023
Q2
$1.03M Buy
+31,406
New +$1.08M ﹤0.01% 740

Other funds holding VTYX

Brown Advisory's VTYX Position: Q1 2026 in Review

Brown Advisory sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 37,160 shares — an estimated $336K sold.

Brown Advisory first reported a position in VTYX in Q2 2023 and held it in 11 quarters. The position peaked at $1.48M in Q3 2023. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

  • Brown Advisory reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
  • Brown Advisory sold 37,160 Ventyx Biosciences shares in Q1 2026, an estimated $336K.
  • Brown Advisory first reported a position in Ventyx Biosciences in Q2 2023 and held it in 11 quarters.
  • Brown Advisory's Ventyx Biosciences position peaked at $1.48M in Q3 2023.
  • 1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on Brown Advisory's 13F filing for Q1 2026, filed 15 May 2026.